Login
Join
FOLLOW:
Subscribe Free
Magazine
eNewsletter
Checkout
Menu
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
More
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
Current / Back Issue
Features
Editorial
Columns
Digital Edition
eNewsletter Archive
Our Team
Editorial Guidelines
Subscribe Now
Advertise Now
Top Features
Working in Tandem: Effective Security for Weight-loss Drug Packaging
Navigating Global CDMO Trends
Anti-Counterfeiting Technology
Making the Most of Real-World Data in Clinical Trials
Inflation Reduction Act and the Impact on Biosimilars
Breaking News
Online Exclusives
Industry News
Collaborations & Alliances
Promotions & Moves
Trials & Filings
Financial Reports
Bio News & Views
Custom Sourcing News
Packaging & Tracking
CRO News
Live From Shows
Top News
Novavax Enters Co-Exclusive Licensing Agreement with Sanofi
MAbxience Names New Chief Executive Officer
Ribobay Pharma Integrates Cytvia’s FlexFactory Platform for Oligonucleotides
WestGene’s mRNA Therapeutic Cancer Vaccine Approved by FDA
5 Prime Sciences, Lilly Partner to Advance Cardio-Metabolic Disease Drug Development
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
ExcellGene, Cytovance Partner to Advance Biologics Development and Manufacture
Cellipont Bioservices, Adva Biotechnology Partner to Optimize Cell Therapy Mfg.
ARTBIO, Nucleus RadioPharma Enter Manufacturing & Supply Pact
Solvias Announces New Biotech Site in North Carolina
Collaboration and Partnering on Advanced Manufacturing Technologies
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Clinical Trial Modernization - Optimizing the Supply of Decentralized Studies
Strategies for Navigating the Evolving Pharmaceutical Supply Chain Landscape
[WEBINAR] Mitigating Supply Chain Risks in an Age of Disruption
Tower Cold Chain Introduces KTEvolution 12 Containers
Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Novavax Enters Co-Exclusive Licensing Agreement with Sanofi
MAbxience Names New Chief Executive Officer
WestGene’s mRNA Therapeutic Cancer Vaccine Approved by FDA
5 Prime Sciences, Lilly Partner to Advance Cardio-Metabolic Disease Drug Development
Novo Nordisk, Metaphore Biotechnologies Enter Obesity Therapeutics Research Pact
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
"3 Key Trends" with Rob Feltz
Cellares Launches Cell Q Automated cGMP QC Workcell for Cell Therapies
TATAA Biocenter Awarded GLP Accreditation
Anti-Counterfeiting Technology
Do You Know Your Product's Impurity Profile?
Companies
Categories
Corporate Capabilities
Add New Company
Contract Service Directory Companies
Syngene International Ltd.
Abzena
Solvias USA, LLC
Vetter Pharma International
AMERIPHARMA
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Jobs
Contract Service Directory Companies
Syngene International Ltd.
Abzena
Solvias USA, LLC
Vetter Pharma International
AMERIPHARMA
Webinars
Live From Shows
Magazine
Current / Back Issue
Features
Editorial
Columns
Editorial Guidelines
Subscribe Now
Advertise Now
Enewsletter Archive
Digital Edition
Directory
Companies
Categories
Corporate Capabilities
Add Your Company
Manufacturing
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
cGMP Manufacture
Packaging
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Development
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Compliance
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
Top 20 Pharma & BioPharma
Contract Pharma Direct
Breaking News
Online Exclusives
Slideshows
Experts Opinions
Surveys
Outsourcing Survey
Salary Survey
Glossary
Videos
White Papers
Podcasts
Infographics
Microsites
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Contract Pharma Conference
Contract Pharma Conference
Speakers
Exhibitors
Conference Sessions
eBook
Webinars
Events
Industry Events
Live from Show Events
Webinars
Classifieds / Job Bank
Classifieds
Job Bank
About Us
About Us
Contact Us
Advertise With Us
Privacy Policy
Terms of Use
Financial Reports
All News
Bio News
Breaking News
Collaborations & Alliances
CRO News
Custom Sourcing News
Financial Reports
Industry News
Packaging & Tracking
Pharma Matters Q&A
Promotions & Moves
Reader Showcase
Trials & Filings
VideoBites
Breaking News
|
Financial Reports
J&J FY Revenues up 14%
Janssen COVID-19 Vaccine contributes $1.6 billion in the quarter and $2.4 billion for the year.
02.02.22
Breaking News
|
Financial Reports
Abbvie FY Revenues up 23%
Revenues from the neuroscience portfolio up 19% and global Botox Therapeutic revenues were up 18% in the quarter.
02.02.22
Breaking News
|
Financial Reports
FibroBiologics Plans to Go Public
Secures $100 million capital commitment from GEM.
11.16.21
Clinical Trials
|
Financial Reports
PPD's 3Q Revenues up 27%
Clinical Development Services revenue up 26% and Laboratory Services revenue grew 29%.
11.02.21
Financial Reports
Biogen's 3Q Revenues Down 18%
Multiple sclerosis sales continue to decline, questions around Alzheimer's drug Aduhelm impact sales.
11.02.21
Financial Reports
Lilly's 3Q Revenues up 18%
COVID-19 antibodies sales were $217.1 million in the quarter.
11.01.21
Financial Reports
BMS 3Q Revenues up 10%
Revlimid, Eliquis, Opdivo and new products Reblozyl, Inrebic, Onureg, Zeposia, Breyanzi, and Abecema drive growth.
11.01.21
Financial Reports
J&J Pharmaceutical Sales up 14% in the Quarter
COVID-19 Vaccine contributes $502 million in sales.
10.19.21
Breaking News
|
Financial Reports
BioNTech’s 2Q Revenue Soars
Growth due to rapid increases in the supply of BNT162b2 as BioNTech and Pfizer evaluate a third dose to boost efficacy against Delta variant.
08.09.21
Breaking News
|
Financial Reports
Amgen's 2Q Results
Product sales up 3% in the quarter while earnings were impacted by $1.5 billion in acquired in-process R&D.
08.04.21
Breaking News
|
Financial Reports
Veklury Drives 2Q Growth for Gilead
Veklury (remdesivir) with sales of $829 million offsets loss of exclusivity of Truvada and Atripla in the U.S. with sales down 72% and 42%, respectively.
07.30.21
Financial Reports
AbbVie's 2Q Revenue up 34%
New immunology assets Skyrizi and Rinvoq contribute more than $1 billion of combined sales in the quarter.
07.30.21
Breaking News
|
Financial Reports
BMS 2Q Revenues up 16%
Top sellers Revlimid, Eliquis and Opdivo drive growth while established brands were down 64%.
07.30.21
Financial Reports
J&J's 2Q Pharma Sales Up 17%
STELARA and DARZALEX sales drive growth with sales up 34% to $2.3 billion and up 59% to $1.4 billion in the quarter, respectively.
07.29.21
Breaking News
|
Financial Reports
Pfizer's 2Q Revenues Up 92%
COVID-19 vaccine BNT162b2 contributes $7.8 billion in sales and alliance revenues.
07.29.21
Financial Reports
Financial Report: Roche 1H Results
Diagnostics Division sales grew 49% due to high demand for COVID-19 tests and strong momentum in routine testing.
07.22.21
Financial Reports
Pfizer 1Q Revenues up 45% Driven by COVID Vax
Vaccine sales were $4.9 billion in the quarter, with BNT162b2 contributing $3.5 billion in global revenues.
Kristin Brooks
05.05.21
Breaking News
|
Financial Reports
Gilead Revenues up 16% in the Quarter
Veklury drives growth in the quarter, offsetting significant declines in HIV, HCV franchises.
Kristin Brooks
04.30.21
Breaking News
|
Financial Reports
Abbvie's 1Q Reveneus up 51%
Aesthetics portfolio drives growth in the quarter with Botox Cosmetic sales up 45%.
Kristin Brooks
04.30.21
Breaking News
|
Financial Reports
Johnson & Johnson 1Q Results
Pharmaceutical sales up 10% in the quarter driven by DARZALEX, STELARA, INVEGA SUSTENNA, and IMBRUVICA.
Kristin Brooks
04.20.21
Breaking News
Novavax Enters Co-Exclusive Licensing Agreement with Sanofi
MAbxience Names New Chief Executive Officer
Ribobay Pharma Integrates Cytvia’s FlexFactory Platform for Oligonucleotides
WestGene’s mRNA Therapeutic Cancer Vaccine Approved by FDA
5 Prime Sciences, Lilly Partner to Advance Cardio-Metabolic Disease Drug Development
View Breaking News >
CURRENT ISSUE
April 2024
Anti-Counterfeiting Technology
Navigating Global CDMO Trends
Weight-loss Drug Packaging
Clinical Supply CDMOs
Industry Experts Weigh in on Oral Solid Dosage
Newsmakers Q&A: Almac Group
Economical Mobile Workstations for Lower-Grade Cleanrooms
Pharmaceutical Manufacturing Equipment & Trends
Insight Into Obesity-Related Clinical Research
Inflation Reduction Act and the Impact on Biosimilars
View More >